HEADER MEMBRANE PROTEIN 30-MAR-20 6YHI TITLE SOLUTION NMR STRUCTURE OF APP G38L MUTANT TMD COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMYLOID-BETA PRECURSOR PROTEIN G38L MUTANT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: AMYLOID PRECURSOR PROTEIN TRANSMEMBRANE DOMAIN; COMPND 5 SYNONYM: APP,ABPP,APPI,ALZHEIMER DISEASE AMYLOID PROTEIN,AMYLOID COMPND 6 PRECURSOR PROTEIN,AMYLOID-BETA A4 PROTEIN,CEREBRAL VASCULAR AMYLOID COMPND 7 PEPTIDE,CVAP,PREA4,PROTEASE NEXIN-II,PN-II,AMYLOID-BETA PRECURSOR COMPND 8 PROTEIN G38L MUTANT; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606 KEYWDS APP, GAMMA SECRETASE, TRANSMEMBRANE, MEMBRANE PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR M.SILBER,C.MUHLE-GOLL REVDAT 2 23-DEC-20 6YHI 1 JRNL REVDAT 1 09-DEC-20 6YHI 0 JRNL AUTH M.SILBER,M.HITZENBERGER,M.ZACHARIAS,C.MUHLE-GOLL JRNL TITL ALTERED HINGE CONFORMATIONS IN APP TRANSMEMBRANE HELIX JRNL TITL 2 MUTANTS MAY AFFECT ENZYME-SUBSTRATE INTERACTIONS OF JRNL TITL 3 GAMMA-SECRETASE. JRNL REF ACS CHEM NEUROSCI V. 11 4426 2020 JRNL REFN ESSN 1948-7193 JRNL PMID 33232115 JRNL DOI 10.1021/ACSCHEMNEURO.0C00640 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER A. T. ET.AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6YHI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1292107620. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT PA REMARK 210 SAMPLE CONTENTS : 500 UM APP G38L, 80% TFE-D2, 20% REMARK 210 H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 1H-1H-NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : CP TCI REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARIA 2.3.2, CCPNMR ANALYSIS REMARK 210 2.4.2 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 400 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : 20 STRUCTURES FOR LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 3000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 4 LYS A 28 -33.67 -142.52 REMARK 500 5 ASN A 27 -75.61 66.96 REMARK 500 7 LYS A 28 -61.90 -135.46 REMARK 500 8 LYS A 28 -6.66 -162.77 REMARK 500 10 ASN A 27 85.93 56.58 REMARK 500 11 LYS A 28 -70.11 -158.95 REMARK 500 15 LYS A 28 -37.13 -160.87 REMARK 500 16 ASN A 27 -52.26 -144.67 REMARK 500 18 ASN A 27 -55.99 -165.30 REMARK 500 20 ASN A 27 -29.25 -148.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34507 RELATED DB: BMRB REMARK 900 SOLUTION NMR STRUCTURE OF APP TMD DBREF 6YHI A 26 55 UNP P05067 A4_HUMAN 697 726 SEQADV 6YHI LEU A 38 UNP P05067 GLY 709 ENGINEERED MUTATION SEQRES 1 A 30 SER ASN LYS GLY ALA ILE ILE GLY LEU MET VAL GLY LEU SEQRES 2 A 30 VAL VAL ILE ALA THR VAL ILE VAL ILE THR LEU VAL MET SEQRES 3 A 30 LEU LYS LYS LYS HELIX 1 AA1 ILE A 31 LYS A 53 1 23 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1